Potential role of proteasome on c-jun related signaling in hypercholesterolemia induced atherosclerosis  by Sozen, Erdi et al.
Redox Biology 2 (2014) 732–738 
R
P
h
E
D
a
A
R
R
A
K
A
H
P
J
A
V
 
I
a
i
s
w
c
s
t
[
(
a
e
p
t
m
t
r
2
l
hContents lists available at ScienceDirect 
Redox Biology 
j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / r e d o x 
esearch Paper 
otential role of proteasome on c-jun related signaling in 
ypercholesterolemia induced atherosclerosis 
rdi Sozen, Betul Karademir, Burak Yazgan, Perinur Bozaykut, Nesrin Kartal Ozer * 
epartment of Biochemistry, Faculty of Medicine, Genetic and Metabolic Diseases Research Center (GEMHAM), Marmara University, 34668 Haydarpasa, Istanbul, Turkey 
 r t i c l e i n f o 
rticle history: 
eceived 26 December 2013 
eceived in revised form 21 February 2014 
ccepted 21 February 2014 
eywords: 
therosclerosis 
ypercholesterolemia 
roteasome 
NK1 
P-1 
itamin E 
a b s t r a c t 
Atherosclerosis and its complications are major causes of death all over the world. One of the major risks of
atherosclerosis is hypercholesterolemia. During atherosclerosis, oxidized low density lipoprotein (oxLDL) 
regulates CD36-mediated activation of c-jun amino terminal kinase-1 (JNK1) and modulates matrix metal- 
loproteinase (MMP) induction which stimulates inﬂammation with an invasion of monocytes. Additionally, 
inhibition of proteasome leads to an accumulation of c-jun and phosphorylated c-jun and activation of activa- 
tor protein-1 (AP-1) related increase of MMP expression. We have previously reported a signiﬁcant increase 
in cluster of differentiation 36 (CD36) mRNA levels in hypercholesterolemic rabbits and shown that vitamin 
E treatment prevented the cholesterol induced increase in CD36 mRNA expression. In the present study, our 
aim is to identify the signaling molecules / transcription factors involved in the progression of atherosclerosis 
following CD36 activation in an in vivo model of hypercholesterolemic (induced by 2% cholesterol containing 
diet) rabbits. In this direction, proteasomal activities by ﬂuorometry and c-jun, phospo c-jun, JNK1, MMP-9 
expressions by quantitative RT-PCR and immunoblotting were tested in aortic tissues. The effects of vitamin 
E on these changes were also investigated in this model. As a result, c-jun was phosphorylated following 
decreased proteasomal degradation in hypercholesterolemic group. MMP-9 expression was also increased in 
cholesterol group rabbits contributing to the development of atherosclerosis. In addition, vitamin E showed 
its effect by decreasing MMP-9 levels and phosphorylation of c-jun. 
c © 2014 The Authors. Published by Elsevier B.V. 
This is an open access article under the CC BY-NC-ND license 
( http: // creativecommons.org / licenses / by-nc-nd / 3.0 / ). ntroduction 
Atherosclerosis is a chronic inﬂammatory disease which is associ- 
ted with the presence of fatty plaques in the arterial wall [ 1 ]. Dur- 
ng atherosclerosis, smooth muscle cells become activated by oxLDL, 
tart to proliferate, and migrate into the intima of the arterial wall 
here they form foam cells [ 2 ]. Many studies have shown that in- 
rease of oxLDL have signiﬁcant roles in the induction of oxidative 
tress related changes [ 3 ]. Hypercholesterolemia and increased oxida- 
ive stress have been involved in the development of atherosclerosis 
 4 , 5 ]. In addition, plasma levels of oxidized LDL and malondialdehyde 
MDA)-modiﬁed LDL are related to each other which are also known 
s parameters of oxidative stress in acute and stable coronary artery Abbreviations: AP-1, activator protein-1; CD36, cluster of differentiation 36; ERAD, 
ndoplasmic-reticulum-associated protein degradation; GAPDH, glyceraldehyde-3- 
hosphate dehydrogenase; JNK, c-Jun amino terminal kinase; LDL, low density lipopro- 
ein; MAPK, mitogen-activated protein kinase; MDA, malondialdehyde; MMP, matrix 
etallo proteinase; oxLDL, oxidized low density lipoprotein; TNF α, tumor necrosis fac- 
or α; UPS, ubiquitin-proteasome system; HPLC, high-performance liquid chromatog- 
aphy; TBA, thiobarbituric acid. 
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213-2317/ $ - see front matter c © 2014 The Authors. Published by Elsevier B.V. This is an
icenses / by-nc-nd / 3.0 / ). 
ttp://dx.doi.org/10.1016/j.redox.2014.02.007 disease [ 6 ]. Meanwhile alpha tocopherol, the most active form of vi- 
tamin E, shows its protective effects by inhibiting smooth muscle cell 
proliferation [ 7 , 8 ] and reduction of scavenger receptor CD36 expres- 
sion in hypercholesteromic rabbits [ 9 ]. 
During atherosclerosis, the low density lipoprotein (LDL)-induced 
signaling pathway is stimulated following the uptake of cholesterol 
into the cell via oxLDL including mitogen-activated protein kinase 
(MAPK), JNK, c-jun and AP-1, known as a transcription factor which 
plays a key role on MMP expression [ 10 ]. In macrophages, supple- 
mentation with oxLDL give rise to recruitment of Lyn and activation of 
JNKs, known as stress-activated protein kinases, in a CD36-dependent 
manner. Studies using JNK inhibitors demonstrated a signiﬁcant de- 
crease in the uptake of oxLDL and foam cell formation [ 11 ]. The tran- 
scription factor AP-1 is a dimer protein, composed of basic region- 
leucine zipper (bZIP) proteins that belong to the Jun and Fos families 
[ 12 ]. Oxidative activation of JNK1 promotes the phosphorylation of 
c-jun and leading to the transactivation of AP-1-regulated genes [ 13 ]. 
Proteasomes are very complex machines that are involved in the 
proteolytic degradation of proteins for the regulation of cell home- 
ostasis which includes “quality control” of newly synthesized proteins 
(ERAD), transcription factor regulation, neurodegenerative diseases, 
atherosclerosis and inﬂammatory processes [ 14 ]. Many studies show  open access article under the CC BY-NC-ND license ( http: // creativecommons.org / 
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 that, oxidative stress mediated protein aggregates have a key role in
the inhibition of proteasome [ 15 ]. Both components of AP-1, c-jun
and c-fos are known to be degraded by the proteasome. In a recent
study, UVA mediated induction of protein aggregate formation results
in the inhibition of proteasome which is accompanied by phospho-
rylation of c-jun and increased AP-1 activity leading to an enhanced
MMP mRNA expression [ 16 ]. OxLDL may also stimulate the invasion
of monocytes which results in inﬂammation by increasing the MMP
production [ 1 ]. MMPs increase matrix degrading activity and accel-
erate leukocyte leakage into the regions of atherosclerotic plaques.
Clinical studies improve the important role of MMPs in morphogene-
sis, and tissue remodeling, in the progress of arthritis, atherosclerosis,
asthma and tumor formation [ 17 ]. MMP-9 degrades type IV collagen,
the major constituent of basement membranes, and is released by
macrophages, smooth muscle cells, and endothelial cells [ 18 ]. En-
hanced MMP-9 levels in plasma have been shown in cardiovascular
diseases [ 19 ]. 
In the present study, we investigated proteasomal activity, mRNA
expressions of c-jun, JNK1, MMP-9 and the protein expressions of c-
jun, phospho c-jun, JNK1, MMP-9 protein expressions in rabbit aorta.
Since MMP-9 is a crucial enzyme for the progression of atheroscle-
rosis, the underlying pathway for its induction should be highlighted
in hypercholesterol induced atherosclerosis. In addition, the role of
vitamin E in this pathway was investigated. The results show that
increased MMP-9 activity resulted in an induction of atherosclerotic
development in cholesterol group rabbits. This increase was found to
be correlated with a decrease in proteasomal activity which is thought
to be the reason for c-jun phosphorylation following the decrease of
its degradation. In this direction, vitamin E showed its protective role
by decreasing MMP-9 expressions correlated with a decrease of c-jun
phosphorylation. But in vitamin E treated group proteasome was not
found to be directly related to this pathway. 
Material and methods 
Animal model 
All experimental procedures were approved by the Marmara
University Ethics Committee, Istanbul (protocol number 062008).
Twenty-one male albino rabbits (2–3 months old) were assigned ran-
domly to three groups which were fed with 100 g / day of vitamin E
poor diet. The ﬁrst control group was only fed with vitamin E poor
diet. The second group was fed with vitamin E poor diet containing 2%
cholesterol and the third group was fed with vitamin E poor diet con-
taining 2% cholesterol with daily intramuscular injections of vitamin
E (50 mg / kg). After 4 weeks, following overnight fasting, rabbits were
anesthetized using 50 mg / kg ketamine hydrochloride and 5 mg / kg
xylazine hydrochloride. The blood was taken for cholesterol, vitamin
E and MDA measurements. The aortic tissues of each animal were
removed and ﬁxed in formalin for microscopic examination, in RNA
stabilization reagent for quantitative RT-PCR and were rapid-frozen
in liquid nitrogen, stored at −80 ◦C for immunoblotting experiments. 
Measurement of cholesterol, vitamin E and MDA in Serum 
Serum cholesterol levels were determined using an automated
enzymatic technique by Hitachi Modular system P800 (Roche). The
levels of alpha-tocopherol were determined in serum samples by us-
ing reversed-phase high-performance liquid chromatography (HPLC)
according to Nierenberg and Nann [ 20 ]. Brieﬂy, samples were dis-
solved in ethanol and applied to a Waters Symmetry C18 column
(5 μm, 4.6 × 250 mm). MeOH: dH2O (95:5, v / v) was used as mo-
bile phase and detections were performed by UV detector (Waters)
at 294 nm. 
MDA was determined according to Wong et al. [ 21 ] with modi-
ﬁcations of Sommerburg et al. [ 22 ] as the thiobarbituric acid (TBA)reactive substance. Phosphoric acid (440 mM), sample or MDA stan-
dard, and TBA solution (42 mM) were incubated at 100 ◦C for 60 min.
After the incubation, samples and standards were cooled on ice and
diluted 1:1 (v: v) with NaOH (0.1 M) in methanol. After then, all sam-
ples were centrifuged at 10,000 g for 2 min. Aliquots of the derivatized
samples were applied to the reversed phase HPLC and separated by
isocratic elution with phosphate buffer (50 mM, pH 6.8) containing
40% (v / v) methanol. TBA–MDA complex was detected by means of
ﬂuorescence using an excitation wavelength of 525 nm and emission
of 550 nm. 
Microscopic examination 
The samples were ﬁxed in 10% buffered formaldehyde for 4 h then
dehydrated and incubated in xylol for 1 h. This process was repeated
and the tissue slices were embedded in parafﬁn and sectioned in
5 μm thickness. Sections were stained with hemotoxylene eosin for
the microscopic examination. 
Proteasome activity analysis by ﬂuorometry 
Aortic tissues were lysed in 1 mM dithiothreitol by vigorous shak-
ing for 1 h at 4 ◦C. The lysates were centrifuged at 14,000 g for
30 min and supernatants were incubated in 225 mM Tris buffer
(pH 7.8) containing 7.5 mM MgOAc, 7.5 mM MgCl 2 , 45 mM KCl, and
1 mM dithiothreitol. The ﬂuorogenic peptide succinyl-LLVY-methyl
coumarin was used as a substrate at a concentration of 200 M to mea-
sure chymotrypsin-like activity of the proteasome. After 30 min of
incubation at 37 ◦C, methyl coumarin liberation was measured with a
ﬂuorescence reader (360 nm excitation / 485 nm emission) and calcu-
lated using free methyl coumarin as standards. To exclude other pro-
tease activities, the selective proteasome inhibitor lactacystin with
the ﬁnal concentration of 20 μM was used in the reaction, and pro-
teasome activity was calculated as the difference between the total
activity and the remaining activity in the presence of lactacystin. 
Measurement of mRNA expressions in aortic tissue with quantitative 
RT-PCR 
Total RNAs were isolated with RNA Midi Kit (QIAGEN) from 200 mg
of rabbit aorta. Smartspec spectrophotometry (BIO-RAD) was used
for the determination of purity and amount of isolated RNA. cDNA
was synthesized with Transcriptor High Fidelity cDNA Synthesis kit
(ROCHE) using 100 ng total RNA. Quantitative reverse transcriptase
PCR was applied to cDNA by using QuantiTect PCR Sybr Green kit
(QIAGEN) and Rotor Gene Q-RT PCR system (QIAGEN). The results
normalized to GAPDH mRNA expression results. The sequences of
primers used were 
rabbit JNK1 forward, 5 ′ -GTGCTTTTCCCAGCTGACTC-3 ′ ; 
rabbit JNK1 reverse, 5 ′ -ATCGTGTGTTCCCTTTCGTC-3 ′ ; 
rabbit c-jun forward, 5 ′ -ACAGAGCATGACCCTGAACC-3 ′ ; 
rabbit c-jun reverse, 5 ′ -TTGCTGGACTGGATGATGAG-3 ′ ; 
rabbit MMP-9 forward, 5 ′ -AACACACACGACGTCTTCCA-3 ′ ; 
rabbit MMP-9 reverse, 5 ′ -TGCAGGATGTCAAAGCTCAC-3 ′ ; 
rabbit GAPDH forward, 5 ′ -GCGCCTGGTCACCAGGGCTGCTT-3 ′ ; 
rabbit GAPDH reverse, 5 ′ -TGCCGAAGTGGTCGTGGATGACCT-3 ′ . 
Immunoblotting to measure protein expressions in aortic tissue 
200 mg of thoracic aorta was homogenized at 20,000 rpm for
20 s with Ultraturrax homogenizator and centrifuged at 15,000 g for
20 min. The protein concentrations of the supernatants were de-
termined with the Bradford protein assay. 40 μg of samples were
separated with 10–12% SDS-PAGE gels, and transferred to a nitro-
cellulose membrane. The antibodies against JNK (AnaSpec), MMP-9
734 E. Sozen et al. / Redox Biology 2 (2014) 732–738 
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tAbcam), c-jun (Novus Biologicals), phospho c-jun (Cell Signaling) and 
APDH (Novus Biologicals) were used to probe membranes, immun- 
detection was performed with the use of HRP-conjugated secondary 
ntibodies and chemiluminescence kit (Cell Signaling). Blots were vi- 
ualized by X-ray ﬁlms and quantiﬁed by densitometry using ImageJ 
oftware. 
tatistical analysis 
Statistical analysis was performed using Prism 4 (Graph-Pad) soft- 
are. For determination of statistical signiﬁcances of differences, one- 
ay ANOVA was performed followed by multiple comparisons using 
he Student ’ s t test. P -value less than 0.05 has been accepted to be 
tatistically signiﬁcant.ResultsSerum cholesterol vitamin E and MDA 
evels after four weeks 
Supplementation of 2% cholesterol for 4 weeks resulted in ap- 
roximately 30-fold increase of serum cholesterol in cholesterol and 
holesterol + vitamin E groups compared to control group ( Table 1 ). 
dditionally, vitamin E treatment enhanced serum vitamin E levels 
pproximately 8-fold in cholesterol + vitamin E group ( Table 1 ). In 
holesterol group, serum vitamin E levels seem to be increased since 
itamin E which is a fat-soluble vitamin, is carried by LDL cholesterol 
hrough the blood. In addition, feeding with cholesterol diet resulted 
 signiﬁcant increases (approximately 6 fold) in serum lipid perox- 
de (MDA) levels of the rabbits as shown in Table 1 . There was no 
igniﬁcant change when cholesterol + vitamin E group compared to 
holesterol group. 
ight microscopy examination of rabbit aortic tissue 
Thoracic aortae stained with hematoxylin eosin were examined 
y light microscopy ( Fig. 1 ). In control group, integrity of the aorta 
as not disrupted and all layers were intact. However, cholesterol 
ed rabbits exhibited atherosclerotic lesions, endothelial damage and, 
arked thickening of the intima layer compared to control group. In 
he cytoplasm of the intimal cells, cluster of foam cells with lipid accu- 
ulation, and lipid droplets were observed between smooth muscle 
ells. In contrast, foam cell formation was not mostly seen in the in- 
ima and media layers and the structure of elastic ﬁbers of media 
ayer was normal in animals fed cholesterol and treated with vitamin 
 compared to cholesterol group. 
holesterol enriched diet inhibits the proteasome activity in rabbit aorta 
In order to test the role of hypercholesterolemia on proteasome 
ctivity, it was measured by ﬂuorometric detection method in rab- 
it aortic tissues. Our results showed that cholesterol enriched diet 
igniﬁcantly inhibited proteasome activity. While approximately 50% 
ecrease was determined in cholesterol group, there was no signiﬁ- 
ant change in vitamin E group ( Fig. 2 ). 
holesterol enriched diet induces mRNA expression of c-jun and 
hosphorylation of c-jun 
mRNA expression of c-jun was increased following cholesterol 
reatment ( Fig. 3 A) while protein expression was not affected sig- 
iﬁcantly ( Fig. 3B ). However, a signiﬁcant increase (approximately 
-fold) of phospho c-jun protein expression was found in hyperc- 
olesterolemic rabbits compared to control group ( Fig. 3C ). Vitamin 
 treated group showed a signiﬁcant decrease of c-jun mRNA expres- 
ion and phospho c-jun protein expression compared to cholesterol 
roup. Previous studies have shown that proteasomal inhibition leads 
o an accumulation of phosphorylated c-jun and activation of AP- 
 which is known to control MMP expression [ 16 ]. Consistent with 
hese data, we showed that cholesterol and vitamin E play a role in the modulation of proteasome activity and accumulation of phospho 
c-jun. 
Hypercholesterolemia induces JNK1 mRNA expression but not JNK1 
protein expression 
Supplementation of cholesterol enriched diet for four weeks re- 
sults in a high increase (approximately 10-fold) of JNK1 mRNA ex- 
pression in cholesterol group compared to control group ( Fig. 4 A). 
However the increase of JNK1 was not detected in protein expres- 
sion of JNK1 ( Fig. 4B ). Vitamin E showed its effect by decreasing JNK1 
mRNA levels. Regarding these results, it may be suggested that hyper- 
cholesterolemia induces the accumulation of phospho c-jun without 
affecting JNK1 protein levels. 
Effect of cholesterol enriched diet on MMP-9 protein and mRNA 
expressions 
MMP-9 degrades type IV collagen, the major constituent of base- 
ment membranes, and is released by macrophages, smooth muscle 
cells, and endothelial cells [ 18 ]. Elevated MMP-9 levels in plasma 
have been shown in cardiovascular diseases [ 19 ]. Therefore, we tested 
whether the mRNA and protein expressions of MMP-9 were affected 
in hypercholesterolemia induced atherosclerosis. As shown in Fig. 5 A 
and B both mRNA and protein levels of MMP-9 signiﬁcantly increased 
in cholesterol group and a signiﬁcant decrease of mRNA and protein 
levels of MMP-9 in vitamin E treated group was determined compared 
to cholesterol group. 
Discussion 
Atherosclerosis, a chronic inﬂammatory disease of arteries which 
is characterized by the accumulation of plasma lipoproteins that carry 
cholesterol and triglycerides in the arteries, is one of the major causes 
of morbidity and mortality worldwide [ 23 ]. Studies have shown that 
2% cholesterol supplementation for 4 weeks is efﬁcient to investi- 
gate the relationship between hypercholesterolemia and atherogen- 
esis in vivo , in terms of atherosclerotic lesions development which 
is identical to the changes in humans [ 8 , 24 ]. Vitamin E is an im- 
portant micronutrient transported in plasma lipoproteins due to its 
hydrophobic nature. Crucial functions of vitamin E apart from its an- 
tioxidant role has been identiﬁed including the modulation of cellular 
signaling pathways and gene expressions [ 25 ]. Additionally, it is ob- 
served that vitamin E prevents cholesterol-induced atherosclerotic 
lesions and the induction of CD36 mRNA expression [ 7 , 26 ]. Also in 
our previous studies, vitamin E treatment has shown its protective 
effect by decreasing CD36 scavenger receptor expression and me- 
diated reduction of foam cell formation against atherosclerosis [ 9 ]. 
Regarding these data, we aimed to identify the signaling molecules / 
transcription factors involved during the progression of atherosclero- 
sis mainly via matrix metalloproteinase related pathway and the role 
of vitamin E in related signaling mechanisms. 
To conﬁrm our in vivo model of hypercholesterolemia induced 
atherosclerosis we analyzed serum cholesterol levels and atheroscle- 
rotic lesions. Serum blood analysis showed that addition of 2% choles- 
terol for 4 weeks resulted in approximately 30-fold increase of serum 
cholesterol ( Table 1 ) and hypercholesterolemia mediated atheroscle- 
rosis development (endothelial layer disruption, lipid accumulation 
and marked foam cell formation in intimal cells) was conﬁrmed by 
light microscopy experiments in cholesterol group ( Fig. 1 ). In the 
cholesterol + vitamin E group, serum levels of vitamin E increased 
(approximately 8-fold) and the fact that atherosclerotic lesions were 
reduced signiﬁcantly supported that vitamin E treatment has pro- 
tective effects against foam cell development in the biochemical and 
histological points. Increased level of lipid peroxidation, measured as 
E. Sozen et al. / Redox Biology 2 (2014) 732–738 735 
Table 1 
Effect of 2% cholesterol diet and vitamin E treatment for four weeks, serum cholesterol, vitamin E and MDA levels. Data are expressed as mean ± S.D. 
Group Cholesterol (mg / ml) Vitamin E ( μg / ml) MDA ( μmol / L) 
Control 79.0 ± 43.7 6.6 ± 1.9 1.69 ± 0.3 
Cholesterol 2869.2 ± 586.6 † 36.61 ± 11.5 † 6.90 ± 1.7 † 
Cholesterol + Vit E 2337.8 ± 926.8 † 52.9 ± 8.27 † 6.33 ± 1.5 † # 
† p < 0.001, vs . control group. 
# p > 0.05, vs . cholesterol group ( n = 7). 
Fig 1. Representative light microscopic images of rabbit aorta from each group ( ×20). Control group (A), cholesterol group (B), and cholesterol + vitamin E group (C). Cholesterol 
fed rabbits exhibited atherosclerotic lesions and notably vitamin E inhibited foam cell formation and endothelial damage. Fixed aortic tissues in 10% buffered formaldehyde for 4 h 
dehydrated and incubated in xylol for 1 h twice, embedded in parafﬁn. 5- μm-thick sections were stained with hemotoxylene eosin before microscopic screening. 
Fig 2. Effect of cholesterol enriched diet and vitamin E treatment on proteasome 
activity. Data denote mean ± S.D. ** p < 0.01 vs . control group ( n = 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 MDA, was detected as a parameter of oxidative stress in patients dur-
ing coronary heart surgery [ 27 ]. In this study, detection of high MDA
levels in serum reﬂects the effect of high cholesterol diet on the ox-
idative status in vivo . All together, serum cholesterol, vitamin E, MDA
results and microscopic examinations are consistent with our previ-
ous results for hypercholesterolemic rabbit model of atherosclerosis
[ 8 , 9 , 28 ] and also in agreement with literature [ 6 , 27 ]. 
The ubiquitin-proteasome system (UPS) is a machinery, involved
in the degradation, regulation or life-span determination of intracel-
lular proteins [ 14 ]. Oxidative damage to proteins may cause modiﬁ-
cation in protein structure, which leads to formation of cross-linked
protein aggregates [ 29 ]. It has been shown in many studies that pro-
teasomal degradation has multiple and complex effects in many cel-
lular functions such as regulation of cell growth and gene expression
by the degradation of transcriptional regulators, such as p53, c-jun,
and β-catenin [ 30 ] and inhibition of signal transduction cascades
by degradation of activated protein kinases [ 31 ]. Active, phospho-
rylated forms of JNK activate transcription factors belonging to the
AP-1 superfamily (e.g., c-jun), and other proteins through phospho-
rylation [ 32 ]. It has been shown that protein aggregates result in the
inhibition of proteasome which is accompanied by phosphorylation
of c-jun and increased AP-1 activity leading to an enhanced MMP
mRNA expression [ 16 ]. In the present study, we interestingly founda signiﬁcant decrease of proteasome activity in both cholesterol and
cholesterol + vitamin E treated group ( Fig. 2 ). AP-1 comprises a dimer
of the subunits jun and fos which are degraded by UPS [ 33 ]. Several
in vitro and in vivo studies determined the proteasomal degradation
of both proteins [ 34 ]. A decrease of proteasomal activity may result
in accumulation of proteins and therefore phosphorylation of c-jun
protein. In this context, we examined c-jun and phospho c-jun ex-
pressions with RT-PCR and immunoblotting techniques. Cholesterol
group demonstrated an increase of c-jun mRNA expression ( Fig. 3A )
but it was not reﬂected to c-jun protein expression in rabbit aorta
( Fig. 3B ). Additionally, we found a signiﬁcant increase in phospho c-
jun protein expressions ( Fig. 3C ) and vitamin E showed its effect by
decreasing c-jun and phospho c-jun levels approximately to control
group. In this direction we can explain the nonsigniﬁcant change in
c-jun protein levels compared to the dramatic increase in mRNA lev-
els. Since c-jun is activated via phosphorylation, protein levels seem
to be unchanged and phosphorylation is increased. 
To understand the mechanism of c-jun activation, we investigated
JNK1 levels in all groups. In this direction, we found a signiﬁcant in-
crease (approximately 10-fold) of JNK1 mRNA expression in choles-
terol group compared to control group which was decreased in vi-
tamin E treated group ( Fig. 4A ). However, these changes were not
signiﬁcant for protein expression of JNK1 ( Fig. 4B ) which brings the
conclusion of posttranslational modiﬁcation of JNK1. Phosphoryla-
tion of JNKs lead to activation of transcription factors belonging to
the AP-1 superfamily (e.g., c-jun) and other proteins such as Elk-1
and p-53 [ 35 ]. JNKs are expressed in vascular smooth muscle cells
and endothelial cells and activated by a wide range of stimuli such
as oxidative stress, mechanical stretch, hypertension [ 36 –38 ] and re-
ported in atherogenesis for foam cell development in the atheroscle-
rotic plaque by activated scavenger receptor A [ 39 ]. It has been shown
that JNK-1 and JNK-2 were phosphorylated and activated by exposure
of macrophages to oxLDL in a CD36 dependent signaling pathway.
And the inhibition of JNK activation results in reduction of foam cell
formation [ 11 ]. In a carotid artery model of MMP-9 knockout mouse
showed that the defect of MMP-9 can be the result of decrease in
intimal hyperplasia and lumen loss, and an accumulation of intersti-
tial collagen [ 40 ]. It has been shown that MAPK mediated activation
of transcription factor AP-1 increased MMP-9 expression in response
736 E. Sozen et al. / Redox Biology 2 (2014) 732–738 
Fig 3. Effect of cholesterol enriched diet and vitamin E treatment on c-jun and phospho c-jun levels in rabbit aorta. mRNA expression in aortic tissue of each animal was measured 
by quantitative RT-PCR, normalized to GAPDH. Relative mRNA expression in rabbit aorta for c-jun (A). Protein expression analyzed by Western blotting with densitometric analysis 
of protein bands and relative ratios were quantiﬁed and normalized relative to GAPDH against c-jun (B) and phospho c-jun (C) antibodies. Data denote mean ± S.D. * p < 0.05 vs . 
cholesterol group, ( n = 5). *** p < 0.001 vs . cholesterol group, ( n = 5). 
Fig 4. JNK1 mRNA and JNK1 protein expressions in 2% cholesterol diet and vitamin E treatment of rabbit aortic tissues. mRNA expression in aortic tissue of each animal was 
measured by quantitative RT-PCR, normalized to GAPDH. Relative mRNA expression in rabbit aorta for JNK1 (A). Protein expression analyzed by Western blotting with densitometric 
analysis of protein bands and relative ratios were quantiﬁed and normalized relative to GAPDH against JNK1 (B) antibodies. Data denote mean ± S.D. * p < 0.05 vs . cholesterol 
group, ( n = 5). 
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ao tumor necrosis factor α (TNF- α) in human vascular smooth mus- 
le cells [ 41 ]. Another study using a vasodilator cilostazol has shown 
he signiﬁcant inhibition of lipopolysaccharide mediated activation of 
NK which lead to the reduction of MMP-9 levels and downregulation 
f MMP-9 by JNK inhibition resulted in the inhibition of macrophage 
ptake [ 42 ]. Our data showed that both mRNA and protein expres- 
ions of MMP-9 were signiﬁcantly increased in cholesterol group and 
reatment of vitamin E reduced these expressions to control levels. 
This optimized rabbit model in our study is a well accepted model 
or hypercholesterolemia induced atherosclerosis studies. But it has 
lso some limitations regarding the protein sequences for produced antibodies. Also, genetically modiﬁed rabbits are very limited. There- 
fore, regarding the obtained results, our future direction is to conﬁrm 
the studied pathway in in vitro cell culture experiments by using in- 
hibitors and silencing experiments. 
Conclusion 
In summary, our results indicate the role of decreased proteasomal 
activity by high cholesterol diet, that might be related c-jun signaling 
pathways in the atherosclerotic process. We also showed the signif- 
icant effect of vitamin E on c-jun, JNK1, MMP-9 mRNA and phospho 
E. Sozen et al. / Redox Biology 2 (2014) 732–738 737 
Fig 5. Effect of cholesterol enriched diet and vitamin E treatment on MMP-9 protein and mRNA expressions in rabbit aorta. mRNA expression in aortic tissue of each animal 
was measured by quantitative RT-PCR, normalized to GAPDH. Relative mRNA expression in rabbit aorta for MMP-9 (A). Protein expression analyzed by Western blotting with 
densitometric analysis of protein bands and relative ratios were quantiﬁed and normalized relative to GAPDH against MMP-9 (B) antibody. Data denote mean ± S.D. * p < 0.05 vs . 
cholesterol group, ( n = 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 c-jun, MMP-9 protein expressions compared to cholesterol group. Re-
garding our data, high cholesterol diet affects c-jun degradation and
phosphorylation which leads to an enhanced MMP expression and the
proteasome activity as complementary part in hypercholesterolemia
induced atherosclerotic process. Additionally, vitamin E signiﬁcantly
decreases c-jun phosphorylation which may be correlated with the
reduction of MMP-9 expressions. At this point, vitamin E treatment
also inhibited the proteasomal activity compared to control group.
However, vitamin E treatment was not effective to decrease the MDA
formation caused by cholesterol. These results lead us to conclude
that vitamin E induced several signaling pathways other than antiox-
idant signaling in our model. Therefore c-jun response was not found
to be directly related to the proteasomal inhibition. 
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